Covenant Multifamily Offices’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.54M Buy
30,357
+940
+3% +$78.7K 0.46% 34
2021
Q2
$2.46M Buy
+29,417
New +$2.41M 0.45% 35
2020
Q1
Sell
-22,484
Closed -$1.67M 131
2019
Q4
$1.67M Sell
22,484
-2,480
-10% -$174K 0.29% 65
2019
Q3
$1.57M Buy
24,964
+207
+0.8% +$12.3K 0.34% 43
2019
Q2
$1.35M Buy
24,757
+3,598
+17% +$194K 0.3% 53
2019
Q1
$1.14M Buy
21,159
+681
+3% +$42K 0.37% 31
2018
Q4
$1.34M Sell
20,478
-10,192
-33% -$761K 0.51% 24
2018
Q3
$2.41M Buy
+30,670
New +$2.19M 0.85% 15
2017
Q4
Sell
-38,965
Closed -$2.83M 121
2017
Q3
$3.17M Buy
38,965
+659
+2% +$52.1K 2.12% 18
2017
Q2
$3.08M Buy
38,306
+935
+3% +$73.8K 1.95% 15
2017
Q1
$2.93M Buy
37,371
+3,305
+10% +$264K 1.95% 16
2016
Q4
$2.69M Buy
+34,066
New +$2.76M 1.65% 15

Other funds holding CVS

Covenant Multifamily Offices's CVS Position: Q3 2021 in Review

Covenant Multifamily Offices increased its CVS Health (CVS) stake by 3.2% in Q3 2021, buying an estimated $78.7K and bringing the position to 30,357 shares worth $2.54M. The position accounts for 0.46% of the portfolio, ranked #34.

Covenant Multifamily Offices first reported a position in CVS in Q4 2016 and has held it in 12 quarters since. The position peaked at $3.17M in Q3 2017. 2,073 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • Covenant Multifamily Offices held 30,357 shares of CVS Health worth $2.54M as of Q3 2021.
  • Covenant Multifamily Offices bought 940 CVS Health shares in Q3 2021, an estimated $78.7K.
  • CVS Health made up 0.46% of Covenant Multifamily Offices's portfolio in Q3 2021, its #34 holding.
  • Covenant Multifamily Offices first reported a position in CVS Health in Q4 2016 and has held it in 12 quarters since.
  • Covenant Multifamily Offices's CVS Health position peaked at $3.17M in Q3 2017.
  • 2,073 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.